Johnson & Johnson Company Profile
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:35 PM ET
Johnson & Johnson at a glance
Johnson & Johnson (NYSE: JNJ) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in New Brunswick, NJ. Johnson & Johnson is led by Mr. Joaquin Duato and employs about 138,200 people. At a market capitalization of $622.84 billion, it ranks among the largest companies in the US market.
JNJ is a member of the SP500, DJIA. Its SEC Central Index Key (CIK) is 0000200406, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Johnson & Johnson do?
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Johnson & Johnson
- Ticker
- NYSE: JNJ
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Joaquin Duato
- Employees
- 138,200
- Headquarters
- One Johnson & Johnson Plaza, New Brunswick, NJ, United States
- Phone
- 732 524 0400
- Website
- jnj.com
- Market cap
- $622.84B
- SEC CIK
- 0000200406
- Latest annual report
- 10-K · Feb 11, 2026
Index membership
Companies similar to Johnson & Johnson
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ABBVAbbVie Inc. | 276.23 | +1.40% | $488.12B | vs JNJ |
| MRKMerck & Company Inc. | 146.32 | +2.76% | $360.98B | vs JNJ |
| NVSNovartis AG | 143.87 | +0.53% | $273.46B | vs JNJ |
| AZNAstraZeneca PLC | 159.54 | +0.48% | $247.43B | vs JNJ |
| LLYEli Lilly and Company | 1,176.83 | +0.62% | $1.05T | vs JNJ |
| ABTAbbott Laboratories | 99.64 | +1.17% | $172.42B | vs JNJ |
| NVONovo Nordisk A/S | 38.61 | +1.11% | $170.42B | vs JNJ |
| PFEPfizer Inc. | 28.23 | +1.47% | $160.90B | vs JNJ |